These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38211700)

  • 1. Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension.
    Charoenpong P; Hall NM; Keller CM; Ram AK; Murnane KS; Goeders NE; Dhillon NK; Walter RE
    Chest; 2024 Jun; 165(6):1518-1533. PubMed ID: 38211700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Outcome of Methamphetamine-Associated Pulmonary Arterial Hypertension and Dilated Cardiomyopathy.
    Zhao SX; Kwong C; Swaminathan A; Gohil A; Crawford MH
    JACC Heart Fail; 2018 Mar; 6(3):209-218. PubMed ID: 29496022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).
    Charoenpong P; Dhillon N; Murnane K; Goeders N; Hall N; Keller C; Bhuiyan MAN; Walter R
    BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38061804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary arterial hypertension seen in methamphetamine abusers.
    Thompson CA
    Am J Health Syst Pharm; 2008 Jun; 65(12):1109-10. PubMed ID: 18541676
    [No Abstract]   [Full Text] [Related]  

  • 5. Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.
    Zamanian RT; Hedlin H; Greuenwald P; Wilson DM; Segal JI; Jorden M; Kudelko K; Liu J; Hsi A; Rupp A; Sweatt AJ; Tuder R; Berry GJ; Rabinovitch M; Doyle RL; de Jesus Perez V; Kawut SM
    Am J Respir Crit Care Med; 2018 Mar; 197(6):788-800. PubMed ID: 28934596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?
    Chin KM; Channick RN; Rubin LJ
    Chest; 2006 Dec; 130(6):1657-63. PubMed ID: 17166979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine-associated pulmonary arterial hypertension.
    Kolaitis NA; Saggar R; De Marco T
    Curr Opin Pulm Med; 2022 Sep; 28(5):352-360. PubMed ID: 35838374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
    Kolaitis NA; Zamanian RT; de Jesus Perez VA; Badesch DB; Benza RL; Burger CD; Chakinala MM; Elwing JM; Feldman J; Lammi MR; Mathai SC; McConnell JW; Presberg KW; Robinson JC; Sager J; Shlobin OA; Simon MA; Kawut SM; Glidden DV; Singer JP; De Marco T;
    Ann Am Thorac Soc; 2021 Apr; 18(4):613-622. PubMed ID: 33064950
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening Of Pulmonary Hypertension in Methamphetamine Abusers (SOPHMA): rationale and design of a multicentre, cross-sectional study.
    Cheng Y; Tung CK; Chung AKK; Liu WW; Huang D; Chan PH; Lam M; Chan WC; Siu CW; Hai JJ
    BMJ Open; 2019 Aug; 9(8):e027193. PubMed ID: 31375608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine and the risk of pulmonary arterial hypertension.
    Ramirez RL; Perez VJ; Zamanian RT
    Curr Opin Pulm Med; 2018 Sep; 24(5):416-424. PubMed ID: 30036313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-dependent right ventricular hypertrophic gene changes after methamphetamine treatment in mice.
    Labazi H; Nilsen M; MacLean MR
    Eur J Pharmacol; 2021 Jun; 900():174066. PubMed ID: 33789156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine attenuates chronic methamphetamine-induced pulmonary arterial remodelling: possible involvement of serotonin transporter and serotonin 1B receptor.
    Liu M; Wang Y; Wang HM; Bai Y; Zhang XH; Sun YX; Wang HL
    Basic Clin Pharmacol Toxicol; 2013 Feb; 112(2):77-82. PubMed ID: 22900600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review.
    Le Bozec A; Korb-Savoldelli V; Boiteau C; Dechartres A; Al Kahf S; Sitbon O; Montani D; Jaïs X; Guignabert C; Humbert M; Savale L; Chaumais MC
    Eur Respir Rev; 2024 Jul; 33(173):. PubMed ID: 38960611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine and idiopathic pulmonary arterial hypertension: role of the serotonin transporter.
    Rothman RB; Baumann MH
    Chest; 2007 Oct; 132(4):1412-3. PubMed ID: 17934137
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE.
    Muller A; Escribano-Subias P; Fernandes CC; Fontana M; Lange TJ; Söderberg S; Gaine S
    Adv Ther; 2024 Mar; 41(3):1103-1119. PubMed ID: 38216826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
    Siefried KJ; Acheson LS; Lintzeris N; Ezard N
    CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance.
    Saloner R; Paolillo EW; Umlauf A; Moore DJ; Heaton RK; Grant I; Cherner M;
    J Int Neuropsychol Soc; 2019 Sep; 25(8):787-799. PubMed ID: 31179969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity.
    Favoino E; Prete M; Liakouli V; Leone P; Sisto A; Navarini L; Vomero M; Ciccia F; Ruscitti P; Racanelli V; Giacomelli R; Perosa F
    Autoimmun Rev; 2024 Apr; 23(4):103514. PubMed ID: 38181859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines.
    Dinarti LK; Anggrahini DW; Lilyasari O; Siswanto BB; Hartopo AB
    Glob Heart; 2021 Apr; 16(1):23. PubMed ID: 34040936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.